Drugmaker Genentech doubles down on Holly Springs with $2 billion manufacturing plant
cbs17.com
Drugmaker Genentech doubles down on Holly Springs with $2 billion manufacturing plant
HOLLY SPRINGS, N.C. (WNCN) – A California-based drugmaker is doubling down on an expansion project that’s slated to bring hundreds of new jobs to the Triangle area. Genentech, a biotechnology compa…
2 months ago
Genentech Careers
Careers - Wilhelmsen
Careers - Wilhelmsen
wilhelmsen.com
Mar 2, 2016
Graduates
Graduates
novartis.com
Aug 28, 2023
Careers | RailWorks
Careers | RailWorks
railworks.com
Oct 7, 2017
Top videos
Lilli Petruzzelli is a natural problem-solver, constantly exploring new ways to tackle the most complex challenges in drug discovery for patients. She also finds balance in life’s simple joys—like spending time with family and baking. As Senior Vice President of Early Clinical Development, Lilli has woven her love of chemistry, dedication to patient care, and passion for problem-solving into a career that bridges research, medicine, and heart. http://spr.ly/61820Wylg | Genentech
0:12
Lilli Petruzzelli is a natural problem-solver, constantly exploring new ways to tackle the most complex challenges in drug discovery for patients. She also finds balance in life’s simple joys—like spending time with family and baking. As Senior Vice President of Early Clinical Development, Lilli has woven her love of chemistry, dedication to patient care, and passion for problem-solving into a career that bridges research, medicine, and heart. http://spr.ly/61820Wylg | Genentech
FacebookGenentech
472 viewsMar 19, 2025
At Genentech, we push the boundaries of science, always striving for breakthroughs that could change the future for people living with cancer. With breast cancer affecting millions of people, the need for new medicines inspires our team to give their best every day. Hear their stories on what working in breast cancer means to them. #BreastCancerAwarenessMonth | Genentech
1:33
At Genentech, we push the boundaries of science, always striving for breakthroughs that could change the future for people living with cancer. With breast cancer affecting millions of people, the need for new medicines inspires our team to give their best every day. Hear their stories on what working in breast cancer means to them. #BreastCancerAwarenessMonth | Genentech
FacebookGenentech
84.4K viewsOct 10, 2024
Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL). It is also the most common type of NHL, accounting for one out of every three lymphomas and affecting almost 31,000 people in the U.S. Learn more about Lamar’s journey with this condition. | Genentech
0:06
Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL). It is also the most common type of NHL, accounting for one out of every three lymphomas and affecting almost 31,000 people in the U.S. Learn more about Lamar’s journey with this condition. | Genentech
FacebookGenentech
23.2K viewsJul 26, 2024
Genentech Drugs
Genentech CEO says aiming for tolerable, affordable obesity drugs | Haystack News
Genentech CEO says aiming for tolerable, affordable obesity drugs | Haystack News
haystack.tv
2 weeks ago
Genentech CEO says aiming for tolerable, affordable obesity drugs
0:49
Genentech CEO says aiming for tolerable, affordable obesity drugs
MSNReuters
3 weeks ago
Genentech CEO says aiming for tolerable, affordable obesity drugs
Genentech CEO says aiming for tolerable, affordable obesity drugs
MSNMichele Gershberg,Michael
3 weeks ago
Lilli Petruzzelli is a natural problem-solver, constantly exploring new ways to tackle the most complex challenges in drug discovery for patients. She also finds balance in life’s simple joys—like spending time with family and baking. As Senior Vice President of Early Clinical Development, Lilli has woven her love of chemistry, dedication to patient care, and passion for problem-solving into a career that bridges research, medicine, and heart. http://spr.ly/61820Wylg | Genentech
0:12
Lilli Petruzzelli is a natural problem-solver, constantly exploring new ways to tackle the most complex challenges in drug discovery for patients. She also finds balance in life’s simple joys—like spending time with family and baking. As Senior Vice President of Early Clinical Development, Lilli has woven her love of chemistry, dedication to patient care, and passion for problem-solving into a career that bridges research, medicine, and heart. http://spr.ly/61820Wylg | Genentech
472 viewsMar 19, 2025
FacebookGenentech
At Genentech, we push the boundaries of science, always striving for breakthroughs that could change the future for people living with cancer. With breast cancer affecting millions of people, the need for new medicines inspires our team to give their best every day. Hear their stories on what working in breast cancer means to them. #BreastCancerAwarenessMonth | Genentech
1:33
At Genentech, we push the boundaries of science, always striving for breakthroughs that could change the future for people living with cancer. With breast cancer affecting millions of people, the need for new medicines inspires our team to give their best every day. Hear their stories on what working in breast cancer means to them. #BreastCancerAwarenessMonth | Genentech
84.4K viewsOct 10, 2024
FacebookGenentech
Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL). It is also the most common type of NHL, accounting for one out of every three lymphomas and affecting almost 31,000 people in the U.S. Learn more about Lamar’s journey with this condition. | Genentech
0:06
Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL). It is also the most common type of NHL, accounting for one out of every three lymphomas and affecting almost 31,000 people in the U.S. Learn more about Lamar’s journey with this condition. | Genentech
23.2K viewsJul 26, 2024
FacebookGenentech
The scientific community has made significant advancements in multiple sclerosis (MS). Today, we know that early treatment may slow the progression of disability, helping people preserve their mental and physical abilities as long as possible. Learn how our understanding of MS disease progression is evolving. | Genentech
0:08
The scientific community has made significant advancements in multiple sclerosis (MS). Today, we know that early treatment may slow the progression of disability, helping people preserve their mental and physical abilities as long as possible. Learn how our understanding of MS disease progression is evolving. | Genentech
247.5K viewsJan 25, 2024
FacebookGenentech
When first diagnosed with triple-negative breast cancer, Latasha learned the aggressive disease disproportionately affects African American women. She hopes continued research and disease education will lead to a brighter future for the next generation. | Genentech
0:24
When first diagnosed with triple-negative breast cancer, Latasha learned the aggressive disease disproportionately affects African American women. She hopes continued research and disease education will lead to a brighter future for the next generation. | Genentech
55.1K viewsOct 9, 2019
FacebookGenentech
Primary progressive multiple sclerosis (MS), a form of MS, requires people living with the condition to constantly adapt their daily routines. Learn from members of the progressive MS community, and their personal journeys with the disease. | Genentech
0:36
Primary progressive multiple sclerosis (MS), a form of MS, requires people living with the condition to constantly adapt their daily routines. Learn from members of the progressive MS community, and their personal journeys with the disease. | Genentech
280.4K views11 months ago
FacebookGenentech
Genentech
1:51
Genentech
Jun 14, 2012
YahooDailyTicker
Allegra is helping drive breakthroughs in the spinal muscular atrophy (SMA) community and beyond. Hear how some of the initiatives she's worked on are shaping the industry standards in film, fashion, music and more. | Genentech
1:00
Allegra is helping drive breakthroughs in the spinal muscular atrophy (SMA) community and beyond. Hear how some of the initiatives she's worked on are shaping the industry standards in film, fashion, music and more. | Genentech
139 viewsAug 30, 2024
FacebookGenentech
Multiple sclerosis affects everyone differently, but one thing is consistent - progression can start early and be unpredictable. Learn how to work with a healthcare provider to better understand and track this progression. | Genentech
0:22
Multiple sclerosis affects everyone differently, but one thing is consistent - progression can start early and be unpredictable. Learn how to work with a healthcare provider to better understand and track this progression. | Genentech
148.6K views10 months ago
FacebookGenentech
Hear from inspirational Black women living with multiple sclerosis (MS), advocates and caregivers as they discuss personal experiences with MS. | Genentech
0:30
Hear from inspirational Black women living with multiple sclerosis (MS), advocates and caregivers as they discuss personal experiences with MS. | Genentech
759.9K viewsMay 28, 2024
FacebookGenentech
Hear from inspirational Black women who are advocates, caregivers, and living with multiple sclerosis (MS) as they discuss personal experiences with MS. | Genentech
0:39
Hear from inspirational Black women who are advocates, caregivers, and living with multiple sclerosis (MS) as they discuss personal experiences with MS. | Genentech
84.2K viewsJan 25, 2024
FacebookGenentech
Listen to our own Fred Brown, Healthcare Market Director, talk about his career at Genentech and how we’re actively working to foster belonging in our workforce. Bring your unique perspective to our diverse team: https://bit.ly/3MBF6mM | Genentech Jobs
1:19
Listen to our own Fred Brown, Healthcare Market Director, talk about his career at Genentech and how we’re actively working to foster belonging in our workforce. Bring your unique perspective to our diverse team: https://bit.ly/3MBF6mM | Genentech Jobs
110.4K viewsMay 17, 2022
FacebookGenentech Jobs
Why is Genentech the Best Company to Work for? | Video | Stanford eCorner
Why is Genentech the Best Company to Work for? | Video | Stanford eCorner
Sep 10, 2024
stanford.edu
No two breast cancer journeys are the same, and biomarker testing plays an important role in leading to a more personalized treatment approach from the outset. Megan O’Neil, a breast cancer survivor, shares how biomarker testing helped identify the PIK3CA mutation in her tumor. | Genentech
1:01
No two breast cancer journeys are the same, and biomarker testing plays an important role in leading to a more personalized treatment approach from the outset. Megan O’Neil, a breast cancer survivor, shares how biomarker testing helped identify the PIK3CA mutation in her tumor. | Genentech
79.6K viewsDec 12, 2024
FacebookGenentech
What does it look like when local voices lead the way in shaping healthcare? Real, lasting change. True progress happens when we listen to, and partner directly with, the people who know their communities best. We’re working hand-in-hand with local leaders and organizations to break down barriers to care, support health education and expand access to clinical research for underserved communities. It’s about building trust to create a healthier and more equitable future, together. Read the powerf
0:31
What does it look like when local voices lead the way in shaping healthcare? Real, lasting change. True progress happens when we listen to, and partner directly with, the people who know their communities best. We’re working hand-in-hand with local leaders and organizations to break down barriers to care, support health education and expand access to clinical research for underserved communities. It’s about building trust to create a healthier and more equitable future, together. Read the powerf
28.9K views7 months ago
FacebookGenentech
Genentech TV Spot, 'Our Greatest Breakthrough'
Genentech TV Spot, 'Our Greatest Breakthrough'
2 months ago
iSpot.tv
Genentech: Genentech Goes to Town
Genentech: Genentech Goes to Town
Feb 20, 2022
gene.com
Ensuring everyone has access to equitable healthcare requires closing gaps in care, including for rural and underserved communities affected by multiple sclerosis (MS). We recently brought together more than 100 patients, providers and advocates for a community dialogue in Phoenix, Arizona, and heard that limited access to MS specialists continues to pose major challenges for patients and providers alike. When we work together, we can convert community insights into practical, sustainable soluti
0:29
Ensuring everyone has access to equitable healthcare requires closing gaps in care, including for rural and underserved communities affected by multiple sclerosis (MS). We recently brought together more than 100 patients, providers and advocates for a community dialogue in Phoenix, Arizona, and heard that limited access to MS specialists continues to pose major challenges for patients and providers alike. When we work together, we can convert community insights into practical, sustainable soluti
72.7K views7 months ago
FacebookGenentech
Biotech company Genentech breaks ground in Holly Springs
Biotech company Genentech breaks ground in Holly Springs
7 months ago
wral.com
Introducing the new and improved Centennial Way Dog Park! As a part of our annual Genentech Gives Back Week, employees came together to build a playground for our local four-legged friends to run, jump and play. Giving back is core to who we are, and we're proud to partner with the South San Francisco Parks and Recreation Department to make our community a better place for everyone, including our furry companions like Sabi! Learn more about our Gives Back Week tradition: http://spr.ly/6182ADkEu
0:53
Introducing the new and improved Centennial Way Dog Park! As a part of our annual Genentech Gives Back Week, employees came together to build a playground for our local four-legged friends to run, jump and play. Giving back is core to who we are, and we're proud to partner with the South San Francisco Parks and Recreation Department to make our community a better place for everyone, including our furry companions like Sabi! Learn more about our Gives Back Week tradition: http://spr.ly/6182ADkEu
153.9K views7 months ago
FacebookGenentech
Biotech company Genentech breaks ground in Holly Springs
0:48
Biotech company Genentech breaks ground in Holly Springs
7 months ago
cbs17.com
Medra raises $52M, partners with Genentech
Medra raises $52M, partners with Genentech
3 months ago
mobihealthnews.com
GENENTECH: A Rich History of Chemical Engineering Innovation
GENENTECH: A Rich History of Chemical Engineering Innovation
Aug 11, 2023
aiche.org
For nearly 50 years, our expertise in blood cancer has driven us to turn cutting-edge science into meaningful medical breakthroughs. But innovation alone isn’t enough. We’re relentlessly working to ensure people living with blood cancer can access the treatments they need and meeting them where they are by collaborating closely with community oncologists and advocates across the country to help reduce the burdens of treatment. #BloodCancerAwarenessMonth | Genentech
0:40
For nearly 50 years, our expertise in blood cancer has driven us to turn cutting-edge science into meaningful medical breakthroughs. But innovation alone isn’t enough. We’re relentlessly working to ensure people living with blood cancer can access the treatments they need and meeting them where they are by collaborating closely with community oncologists and advocates across the country to help reduce the burdens of treatment. #BloodCancerAwarenessMonth | Genentech
207.4K views6 months ago
FacebookGenentech
Many personalized cancer treatments aim to block out-of-control signals that fuel tumor growth. Targeting the PI3K pathway, which drives the growth of many cancers including #breastcancer, has been a challenging goal for researchers. Anwesha Dey, Senior Director & Scientist in Discovery Oncology at Genentech, uses everyday objects to explain how discoveries are enabling a new scientific advancement which not only blocks mutated signals, but also destroys the mutated proteins. | Genentech
1:31
Many personalized cancer treatments aim to block out-of-control signals that fuel tumor growth. Targeting the PI3K pathway, which drives the growth of many cancers including #breastcancer, has been a challenging goal for researchers. Anwesha Dey, Senior Director & Scientist in Discovery Oncology at Genentech, uses everyday objects to explain how discoveries are enabling a new scientific advancement which not only blocks mutated signals, but also destroys the mutated proteins. | Genentech
274.9K viewsNov 14, 2024
FacebookGenentech
What if we could alter cells to help us fight disease more effectively, or transplant cells to regenerate tissue and restore lost function? Cell therapy is a promising therapeutic strategy that aims to turn cells into living medicines. By replacing or enhancing cells to effectively carry out vital roles, cell therapy can become a powerful treatment for cancer, eye diseases and more. Click to read about how our robust collaborations are complementing our own efforts to drive forward the discovery
0:11
What if we could alter cells to help us fight disease more effectively, or transplant cells to regenerate tissue and restore lost function? Cell therapy is a promising therapeutic strategy that aims to turn cells into living medicines. By replacing or enhancing cells to effectively carry out vital roles, cell therapy can become a powerful treatment for cancer, eye diseases and more. Click to read about how our robust collaborations are complementing our own efforts to drive forward the discovery
30.4K viewsJan 9, 2023
FacebookGenentech
Three days. Thousands of people. Countless #CancerBreakthrough stories. Thanks to all who shared their tales of progress at #ASCO17. | Genentech
0:45
Three days. Thousands of people. Countless #CancerBreakthrough stories. Thanks to all who shared their tales of progress at #ASCO17. | Genentech
116.2K viewsJun 27, 2017
FacebookGenentech
Do you know what questions to ask if you or a loved one is diagnosed with breast cancer? Learn more about the different types of the disease and questions to ask your doctor. | Genentech
0:16
Do you know what questions to ask if you or a loved one is diagnosed with breast cancer? Learn more about the different types of the disease and questions to ask your doctor. | Genentech
72.8K viewsNov 28, 2019
FacebookGenentech
Megan knew breast cancer was a major health challenge, but she had no idea there were so many different types or treatment options until she was diagnosed. | Genentech
1:13
Megan knew breast cancer was a major health challenge, but she had no idea there were so many different types or treatment options until she was diagnosed. | Genentech
257.9K viewsOct 11, 2019
FacebookGenentech
See more